COX-2, NSAID Concomitant Use With GI Protective Drugs Is Similar, Study Says
COX-2 inhibitor patients use gastro-protective drugs at approximately the same rate as patients taking traditional nonsteroidal anti-inflammatory drugs, an Express Scripts-sponsored study suggests
You may also be interested in...
The liver safety profile of Novartis' Prexige appears to be one factor behind FDA's request for additional studies on the COX-2 inhibitor prior to approval in osteoarthritis and acute pain
Four California health plans are mailing $10 coupons to physicians to cover the copay for a new prescription for one of 12 drugs available under the Generic Advantage program
COX-2 inhibitors are over-prescribed for short-term pain and therefore do not achieve the gastrointestinal safety benefit needed to be considered cost-effective, Express Scripts' drug utilization studies conclude